Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyltransferase cDNA

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5313-5318

  Manome, Yoshinobu ^a,b   Watanabe, Michiko ^a   Futaki, Ken ^a   Ishiguro, Haruya ^a   Iwagami, Shinya ^a   Noda, Kazuomi ^a   Dobashi, Hisashi ^a   Ochiai, Yusuke ^a   Ohara, Yuka ^a   Sanuki, Kunitaro ^a   Kunieda, Takehiko ^a   Ohno, Tsuneya ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Microbiology ^*  (Japan)

Author keywords

Brain tumor; Drug resistance; Nitrosourea

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROETHYLNITROSOUREA; COMPLEMENTARY DNA; DNA METHYLTRANSFERASE; METHYLGUANIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CANCER; CANCER CELL; CANCER SURVIVAL; GENETIC TRANSDUCTION; GLIOSARCOMA; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; ETHYLNITROSOUREA; GLIOSARCOMA; MALE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RATS; RATS, INBRED F344; TUMOR CELLS, CULTURED;

EID: 17544366242     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barker M, Hoshino T, Gurcay O, Wilson C. B, Nielsen SL, Downie R and Eliason J: Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 35: 976-986, 1973.
2. Rydberg B, Spurr N and Karran P: cDNA cloning and chromosomal arrangement of the human O6-methylguanine-DNA methyltransferase. J Biol Chem 205: 9563-9569, 1990.
3. Housey GM, Johnson MD, Hsiao WL, O'Brian CA, Murphy JP, Kirschmeier P and Weinstein IB: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343-354, 1988.
4. Chirgwin JM, Przbyla AE, MacDonald RJ and Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
5. Manome Y, Abe M, Hagen MF, Fine HA, and Kufe DW: Enhancer Sequences of the DF3 gene regurate expression of the Herpes Simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res 54: 5408-5413, 1994.
6. Kobayashi N, Allen N, Clendenon NR, and Ko L-W: An improved rat brain tumor model. J Neurosurg 53: 808-815, 1980.
7. Chen ZP, Malapetsa A, McQuillan A, Marcantonio D, Bello V, Mohr G, Remack J, Brent TP and Panasci LC: Evidence for nucleotide excision repair as a modifying factor of O6-methylguanme-DNA methyltransferase-mediated innate chloroethylnitrosourea resistance in human tumor cell lines. Mol Pharmacol 52: 815-820, 1997.
8. Mineura K, Yanagisawa T, Watanabe K, Kowada M and Yasui N: Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy. Int J Cancer 69: 420-425, 1996.
9. Berg SL, Gerson SL, Godwin K, Cole DE, Liu L and Balis FM: Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and time course of peripheral blood mononuclear cell O6-methylguanine-DNA methyltransferase inhibition in the nonhuman primate. Cancer Res 55: 4606-4610, 1995.
10. Debiton E, Cussac BC, Mounetou E, Rapp M, Dupuy JM, Maurizis JC, Veyre A and Madelmont JC: Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl) ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma. Br J Cancer 76: 1157-1162, 1997.
11. Kokkinakis DM, Moschel RC, Vuong TH, Reddy MV, Schold SC, and Pegg AE: Mechanism of depletion of O6-methylguanine-DNA methyltransferase activity in rat tissues by O6-Benzyl-2'-deoxyguanosine. Role of metabolism. In Vivo 10: 297-306, 1996.
12. Marathi UK, Kroes RA, Dolan ME and Erickson LC: Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro. Cancer Res 55: 4281-4286, 1993.
13. Marathi UK, Dolan ME and Erickson LC: Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo. Biochem Pharmacol 48: 2127-2134, 1994.
14. Marathi UK, Dolan ME and Erickson LC: Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Cancer Res 54: 4371-4375, 1994.
15. Mineura K, Izumi I, Watanabe K, Kowada M, Kohda K, Koyama K, Terashima I and Ikenaga M: Enhancing effect of O6-alkylguanine derivatives on chloroethylnitrosourea cytotoxicity toward tumor cells. Int J Cancer 58: 706-712, 1994.
16. Mineura K, Fukuchi M, Kowada M, Terashima I and Kohda K: Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines. Int J Cancer 63: 148-51, 1995.
17. Mineura K, Fukuchi M, Kowada M, Hitomi K, Terashima I and Kohda K: Enhancement effect of O6-fluorobenzylguanines on chloroethylnitrosourea cytotoxicity in tumor cells. Life Sci 58: 8, 1996.
18. Pieper RO, Futscher BW, Dong Q and Erickson LC: Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Cancer Res 51: 1581-1585, 1991.
19. Schold SJ, Kokkinakis DM, Rudy JL, Moschel RC and Pegg AE: Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU. Cancer Res 50: 2076-2081, 1996.
20. Ostrowski LE, Pegram CN, Von WM, Humphrey PA, He XM, Shiota S, Mitra S, Brent TP and Bigner DD: Production and characterization of antipeptide antibodies against human O6-methylguanine-DNA methyltransferase. Cancer Res 51: 3339-3344, 1991.
21. Ballal SK, Isham K and Foote RS: Inhibition of O6-methylguanine-DNA methyltransferase in HeLa S3 cells by antisense oligodeoxy-nucleotides. Saas Bull Biochem Biotechnol 7: 40-43, 1994
22. Citti L, Boldrini L, Preuss I, Kaina B, Mariani L and Rainaldi G: Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/Mex+ transfected cells to mitozolomide. Carcinogenesis 17: 25-29, 1996.
23. Nagane M, Asai A, Shibui S, Nomura K, and Kuchino Y: Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas. Neurosurgery 41: 434-440, 1997.
24. Potter PM, Harris LC, Remack JS, Edwards CC and Brent TP: Ribozyme-mediated modulation of human O6-methylguanine-DNA methyltransferase expression. Cancer Res 53: 1731-1734, 1993.
25. Dong Y, Wen P, Manome Y, Parr M, Hirshowitz A, Chen L, Hirschowitz EA, Crystal R, Weichselbaum R, Kufe DW and Fine HA: In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 7: 713-720, 1996.
26. Manome Y, Wen PY, Hershowitz A, Tanaka T, Rollins BJ, Kufe DW, and Fine HA: Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for nonintracranial tumors. Cancer Immunol Immunother 41: 227-235, 1995.
27. Manome Y, Wen PY, Chen L, Tanaka T, Dong Y, Yamazoe M, Hirshowitz A, Kufe DW, and Fine HA: Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide. Gene Ther 3: 513-520, 1996.
28. Manome Y, Wen PY, Dong Y, Tanaka T, Mitchell BS, Kufe DW and Fine HA: Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med 2: 567-573, 1996.
29. Manome Y, Kunieda T, Wen PY, Koga T, Kufe DW and Ohno T: Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther 9: 1409-1417, 1998.
30. Tanaka T, Manome Y, Wen P, Kufe DW, and Fine HA: Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat Med 3: 437-442, 1997.
31. Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin WJ and Fine HA: Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med 3: 1145-1149, 1997.
32. Futscher BW, Campbell K and Dalton WS: Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil. Cancer Res 52: 5013-5017, 1992.
33. Gomi A, Shinoda S, Sakai R, Hirai H, Ozawa K and Masuzawa T: Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3- nitrosourea. Biochem Biophys Res Commun 227: 558-563, 1996.
34. Gomi A, Shinoda S, Masuzawa T, Ishikawa T, and Kuo MT: Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells. Cancer Res 57: 5292-5299, 1997.
35. Gomi A, Masuzawa T, Ishikawa T, and Kuo MT: Posttranscriptional regulation of MRP/GS-X pump and gamma-glutamylcysteine synthetase expression by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea and by cycloheximide in human glioma cells. Biochem Biophys Res Commun 239: 51-56, 1997.
36. Lefebvre P, Zak P and Laval F: Induction of O6-methylguanine-DNA-methyltransferase and N3-methyladenine-DNA-glycosylase in human cells exposed to DNA-damaging agents. Dna Cell Biol 12: 233-241, 1993.
37. Zaidi NH, Allay E, Ayi TC, Li BF, Dumenco LL, Sy MS and Gerson SL: The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene. Carcinogenesis 16: 1047-1053, 1995.
38. Wang G, Weiss C, Sheng P and Bresnick E: Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents. Biochem Pharmacol 51: 1221-1228, 1996.
39. Maze R, Carney JP, Kelley MR, Glassner BJ, Williams DA and Samson L: Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc Natl Acad Sci USA 93: 206-210, 1996.
40. Maze R, Kapur R, Kelley MR, Hansen WK, Oh SY and Williams DA: Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA. J Immunol 158: 1006-1013, 1997.